Development of a glucocorticoid toxicity index using multi-criteria decision analysis

Autor: Miloslaysky, E, Naden, RP, Bijlsma, JW, Brogan, P, Browns, S, Brunetta, P, Buttgereit, F, Choi, HK, Dicaire, J-F, Gelfand, J, Heaney, L, Lightstone, L, Lu, L, Murrell, D, Petri, M, Rosenbaum, JT, Saag, K, Urowitz, M, Winthrop, KL, Stone, JH

Publikováno v: 2016 ACR/ARHP Annual Meeting

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______1032::add27f94e79273eeadee67a1ebfa6b09
http://hdl.handle.net/10044/1/64209

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Identifying Potential Classification Criteria for Calcium Pyrophosphate Deposition Disease: Item Generation and Item Reduction.

Autor: Tedeschi SK; Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts., Pascart T; Lille Catholic University, Lille, France., Latourte A; Hôpital Lariboisière, Université de Paris, Paris, France., Godsave C; University of Nottingham, Nottingham, UK., Kundakci B; University of Nottingham, Nottingham, UK., Naden RP, Taylor WJ; University of Otago, Wellington, New Zealand., Dalbeth N; University of Auckland, Auckland, New Zealand., Neogi T; Boston University School of Medicine, Boston, Massachusetts., Perez-Ruiz F; Osakidetza, Ezkerraldea-Enkarterri-Cruces, Cruces University Hospital, Biocruces-Bizkaia Health Research Institute, and University of the Basque Country, Spain., Rosenthal A; Medical College of Wisconsin, Milwaukee., Becce F; Lausanne University Hospital, Lausanne, Switzerland., Pascual E; Hospital General Universitario de Alicante and Alicante Institute of Sanitary and Biomedical Research, Alicante, Spain., Andres M; Hospital General Universitario de Alicante and Alicante Institute of Sanitary and Biomedical Research, Alicante, Spain., Bardin T; Hôpital Lariboisière, Université de Paris, Paris, France., Doherty M; University of Nottingham, Nottingham, UK., Ea HK; Hôpital Lariboisière, Université de Paris, Paris, France., Filippou G; Luigi Sacco University Hospital, Milan, Italy., FitzGerald J; David Geffen School of Medicine, University of California, Los Angeles., Guitierrez M; Instituto Nacional de Rehabilitación, Mexico City, Mexico., Iagnocco A; Università degli Studi di Torino, Turin, Italy., Jansen TL; VieCuri Medical Center, Venlo, Noord-Limburg, and University of Twente, Enschede, The Netherlands., Kohler MJ; Massachusetts General Hospital and Harvard Medical School, Boston., Lioté F; Hôpital Lariboisière, Université de Paris, Paris, France., Matza M; Massachusetts General Hospital and Harvard Medical School, Boston., McCarthy GM; Mater Misericordiae University Hospital, Dublin, Ireland., Ramonda R; University of Padova, Padova, Italy., Reginato AM; Brown University, Providence, Rhode Island., Richette P; Hôpital Lariboisière, Université de Paris, Paris, France., Singh JA; University of Alabama at Birmingham and Birmingham Veterans Affairs Medical Center., Sivera F; Hospital General Universitario Elda, Elda, and Universidad Miguel Hernandez, Elche, Spain., So A; Lausanne University Hospital, Lausanne, Switzerland., Stamp LK; University of Otago, Christchurch, New Zealand., Yinh J; Massachusetts General Hospital and Harvard Medical School, Boston., Yokose C; Massachusetts General Hospital and Harvard Medical School, Boston., Terkeltaub R; San Diego Veterans Administration Healthcare Service and University of California-San Diego., Choi H; Massachusetts General Hospital and Harvard Medical School, Boston., Abhishek A; University of Nottingham, Nottingham, UK.

Publikováno v: Arthritis care & research [Arthritis Care Res (Hoboken)] 2022 Oct; Vol. 74 (10), pp. 1649-1658. Date of Electronic Publication: 2022 Jun 30.

Multicriteria decision analysis process to develop new classification criteria for systemic lupus erythematosus.

Autor: Tedeschi SK; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA stedeschi1@bwh.harvard.edu., Johnson SR; Department of Medicine, Toronto Western Hospital, Mount Sinai Hospital, Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada., Boumpas DT; Departments of Internal Medicine and Rheumatology, Clinical Immunology and Allergy, University of Crete, Heraklion, Greece., Daikh D; Department of Medicine, University of California San Francisco, San Francisco, California, USA.; Department of Medicine, VA Medical Center, San Francisco, California, USA., Dörner T; Department of Medicine/Rheumatology and Clinical Immunology, Charite University Hospitals, Berlin, Germany., Diamond B; Center for Autoimmune, Musculoskeletal and Hematopoietic Diseases, Feinstein Institute for Medical Research, Manhasset, New York, USA., Jacobsen S; Copenhagen Lupus and Vasculitis Clinic, Center for Rheumatology and Spine Diseases, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark., Jayne D; Department of Medicine, University of Cambridge, Cambridge, UK., Kamen DL; Department of Medicine, Medical University of South Carolina, Charleston, South Carolina, USA., McCune WJ; Department of Medicine, University of Michigan, Ann Arbor, Michigan, USA., Mosca M; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy., Ramsey-Goldman R; Department of Medicine/Division of Rheumatology, Northwestern University, Chicago, Illinois, USA., Ruiz-Irastorza G; Autoimmune Diseases Research Unit, Department of Internal Medicine, Biocruces Health Research Institute, Hospital Universitario Cruces, University of The Basque Country, Bizkaia, Spain., Schneider M; Rheumatology Department, University Hospital Dusseldorf, Dusseldorf, Germany., Urowitz M; Department of Medicine, Toronto Western Hospital, Mount Sinai Hospital, Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada., Wofsy D; Department of Medicine, University of California San Francisco, San Francisco, California, USA., Smolen JS; Department of Rheumatology, Medical University of Vienna, Vienna, Austria., Naden RP; Department of Medicine, McMaster University, Hamilton, Canada., Aringer M; Department of Medicine III, University Medical Center and Faculty of Medicine Carl Gustav Carus at the TU Dresden, Dresden, Germany., Costenbader KH; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.

Publikováno v: Annals of the rheumatic diseases [Ann Rheum Dis] 2019 May; Vol. 78 (5), pp. 634-640. Date of Electronic Publication: 2019 Jan 28.

Development of a Glucocorticoid Toxicity Index (GTI) using multicriteria decision analysis.

Autor: Miloslavsky EM; Rheumatology, Allergy and Immunology Division, Massachusetts General Hospital, Boston, Massachusetts, USA., Naden RP; Maternal-Fetal Medicine, McMaster University Faculty of Health Sciences, Hamilton, Ontario, Canada., Bijlsma JW; Department of Rheumatology, UMCUtrecht, Utrecht, Netherlands., Brogan PA; Institute of Child Health, University College London, UCL Inst of Child Health, London, UK., Brown ES; Department of Psychiatry, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, USA., Brunetta P; Late Stage Immunology Product Development, Genentech, Inc., South San Francisco, USA., Buttgereit F; Department of Rheumatology and Immunology, Charité University Medicine Berlin, Berlin, Germany., Choi HK; Department of Rheumatology, Harvard Medical School, Boston, Massachusetts, USA., DiCaire JF; Pinnacle, Inc., Montreal, Quebec, Canada., Gelfand JM; University of California-San Francisco, San Francisco, USA., Heaney LG; Queen's University of Belfast, Belfast, UK., Lightstone L; Section of Renal Medicine and Vascular Inflammation, Division of Immunology and Inflammation, Department of Medicine, Imperial College London, Imperial College London, London, UK., Lu N; Department of Rheumatology, Massachusetts General Hospital, Boston, USA., Murrell DF; University of New South Wales, Sydney, New South Wales, Australia., Petri M; Department of Rheumatology, Johns Hopkins University, Baltimore, Maryland, USA., Rosenbaum JT; Casey Eye Institute, Oregon Health and Science University, Portland, Oregon, USA., Saag KS; UAB Division of Clinical Immunology/Rheumatology, University of Alabama at Birmingham, Birmingham, Alabama, USA., Urowitz MB; Center for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital, University of Toronto, Lupus Clinic, Toronto, Canada., Winthrop KL; Oregon Health Sciences University, Portland, Oregon, USA., Stone JH; Massachusetts General Hospital Rheumatology Unit, Harvard Medical School, Rheumatology Clinic, Boston, Massachusetts, USA.

Publikováno v: Annals of the rheumatic diseases [Ann Rheum Dis] 2017 Mar; Vol. 76 (3), pp. 543-546. Date of Electronic Publication: 2016 Jul 29.